SCHEMBL3207308

SCHEMBL3207308

C[C@]1(O)CO[C@H]2[C@@H]1OC[C@@]2(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3880118 1.00
SCHEMBL1723855 0.75
SCHEMBL23081620 0.71 THRB (0.42)
SCHEMBL15696573 0.71
SCHEMBL10016801 0.71 THRB (0.42)
SCHEMBL18837971 0.70
SCHEMBL10016813 0.69
SCHEMBL4296114 0.67
SCHEMBL12930415 0.67
SCHEMBL12899797 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025229079-A1 USE OF COMPOSITIONS CONTAINING 2-ETHYLHEXYL LAURATE FOR TREATING ECTOPARASITES G. POHL-BOSKAMP GMBH & CO. KG (DE) 2025-11-06 WO claimed
EP-4436558-A1 METHOD FOR PRODUCING MEDICATIONS AND VACCINES MSLsolutions GmbH (DE) 2024-10-02 EP claimed
WO-2023148303-A1 METHOD FOR PRODUCING MEDICATIONS AND VACCINES MSLSOLUTIONS GMBH (DE) 2023-08-10 WO claimed
EP-0230226-B1 ANTIMYCOTIC EMULSIONS Kali-Chemie Pharma GmbH (DE) 1991-08-07 EP claimed
EP-0230226-A2 Antimycotic emulsions Kali-Chemie Pharma GmbH (DE) 1987-07-29 EP claimed
EP-4724447-A1 SYNTHESIS OF CYCLIC ACYL SULFOXIMINES Syngenta Crop Protection AG (CH) 2026-04-15 EP disclosed
WO-2025229079-A1 USE OF COMPOSITIONS CONTAINING 2-ETHYLHEXYL LAURATE FOR TREATING ECTOPARASITES G. POHL-BOSKAMP GMBH & CO. KG (DE) 2025-11-06 WO disclosed
EP-4436558-B1 METHOD FOR PRODUCING MEDICATIONS AND VACCINES MSLSOLUTIONS GMBH (DE) 2025-09-24 EP disclosed
US-20250197391-A1 METHODS OF SYNTHESIZING EGFR INHIBITORS ANTARES THERAPEUTICS, INC. 2025-06-19 US disclosed
US-20250153438-A1 METHOD FOR SEPARATING POLYMER ELEMENTS, WHICH WERE PRODUCED BY AN ADDITIVE MANUFACTURING METHOD, BY MEANS OF GRANULAR MEDIA 84J GmbH & Co. KG (DE) 2025-05-15 US disclosed
US-20250134825-A1 METHOD FOR PRODUCING MEDICATIONS AND VACCINES MSLSOLUTIONS GMBH (DE) 2025-05-01 US disclosed
WO-2025061707-A1 SYNTHESIS OF SULFOXIMINES CONTAINING A BENZIMIDAZOLE MOIETY SYNGENTA CROP PROTECTION AG (CH) 2025-03-27 WO disclosed
US-6046163-A Cyclosporin formulation GALENA AS (CZ) 2000-04-04 US disclosed
EP-0938297-A1 IMMUNOMODULATORY FORMULATION GALENA, A.S. (CZ) 1999-09-01 EP disclosed
EP-0874640-A1 CYCLOSPORIN FORMULATION GALENA, A.S. (CZ) 1998-11-04 EP disclosed
WO-1998010747-A1 IMMUNOMODULATORY FORMULATION GALENA AS (CZ) 1998-03-19 WO disclosed
WO-1997026003-A1 CYCLOSPORIN FORMULATION GALENA A S (CZ) 1997-07-24 WO disclosed
US-5639474-A Cyclosporin soft capsule composition HANMI PHARM. IND., LTD. (KR) 1997-06-17 US disclosed
EP-0230226-B1 ANTIMYCOTIC EMULSIONS Kali-Chemie Pharma GmbH (DE) 1991-08-07 EP disclosed
EP-0230226-A2 Antimycotic emulsions Kali-Chemie Pharma GmbH (DE) 1987-07-29 EP disclosed